Mechanism of circadian variation in bone resorption - PubMed (original) (raw)
Clinical Trial
Mechanism of circadian variation in bone resorption
N H Bjarnason et al. Bone. 2002 Jan.
Abstract
The diurnal variation in bone resorption markers is poorly understood and may contain essential information about regulation of bone resorption. To explore the acute regulation of bone resorption we studied bone turnover in 14 postmenopausal women during a randomized, crossover, 24 h study of oral glucose tolerance test (OGTT), normal diet, or fasting. Whereas fasting counteracted variation in bone resorption, as measured by serum C-telopeptide fragments of collagen type 1 degradation (s-CTx), OGTT and normal diet induced a 50% reduction (p < 0.001) over 2 h. For OGTT, s-CTx reverted to baseline levels after 6 h, and for normal diet s-CTx remained suppressed during the afternoon and returned to baseline overnight. Repeated OGTT at 8:00 A.M. and 8:00 P.M. in nine postmenopausal women demonstrated that identical reductions in s-CTx could be obtained at both timepoints with an intermediate return to baseline between tests. A 2 h randomized, crossover study of OGTT and fasting in 23 men and premenopausal women similarly revealed a 50% decrease in s-CTx. A randomized, crossover 2 h study of insulin tolerance test compared with fasting in six men and premenopausal women demonstrated a 20%-30% decrease in s-CTx (p < 0.01-0.05). Nine hour follow-up of ten healthy individuals during a crossover experiment of OGTT, protein, and fat intake revealed a comparable 50% reduction in s-CTx, but distinct profiles of serum glucose and serum insulin. Bone resorption was reduced by intake of food, glucose, fat, and protein and counteracted by fasting, and this seems to have been be independent of age and gender. Both exogenous and endogenous insulin stimulation tests induced a reduction in bone resorption, but this was only partial when compared with the reduction observed during food intake.
Similar articles
- Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps.
Zikán V, Haas T, Stepan JJ. Zikán V, et al. Calcif Tissue Int. 2001 Jun;68(6):352-7. doi: 10.1007/s00223-001-0010-9. Epub 2001 May 21. Calcif Tissue Int. 2001. PMID: 11685423 - Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.
Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell Henriksen E, Qvist P, Alexandersen P, Bang Henriksen D. Christgau S, et al. Bone. 2000 May;26(5):505-11. doi: 10.1016/S8756-3282(00)00248-9. Bone. 2000. PMID: 10773591 - Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
Westberg-Rasmussen S, Starup-Linde J, Hermansen K, Holst JJ, Hartmann B, Vestergaard P, Gregersen S. Westberg-Rasmussen S, et al. Bone. 2017 Apr;97:261-266. doi: 10.1016/j.bone.2017.01.027. Epub 2017 Jan 23. Bone. 2017. PMID: 28126633 Clinical Trial. - Measurement of C-terminal telopeptide of type I collagen (CTX) in serum.
Chubb SA. Chubb SA. Clin Biochem. 2012 Aug;45(12):928-35. doi: 10.1016/j.clinbiochem.2012.03.035. Epub 2012 Apr 6. Clin Biochem. 2012. PMID: 22504058 Review. - Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S. Heshmati HM, et al. J Clin Endocrinol Metab. 1998 Mar;83(3):751-6. doi: 10.1210/jcem.83.3.4627. J Clin Endocrinol Metab. 1998. PMID: 9506720 Review.
Cited by
- Oral calcitonin.
Hamdy RC, Daley DN. Hamdy RC, et al. Int J Womens Health. 2012;4:471-9. doi: 10.2147/IJWH.S24776. Epub 2012 Sep 6. Int J Womens Health. 2012. PMID: 23071417 Free PMC article. - The Gut-Bone Axis in Diabetes.
Maagensen H, Helsted MM, Gasbjerg LS, Vilsbøll T, Knop FK. Maagensen H, et al. Curr Osteoporos Rep. 2023 Feb;21(1):21-31. doi: 10.1007/s11914-022-00767-2. Epub 2022 Nov 28. Curr Osteoporos Rep. 2023. PMID: 36441432 Review. - Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study.
Heimgartner N, Graf N, Frey D, Saleh L, Wüthrich RP, Bonani M. Heimgartner N, et al. Kidney Blood Press Res. 2020;45(5):758-767. doi: 10.1159/000510565. Epub 2020 Sep 30. Kidney Blood Press Res. 2020. PMID: 32998144 Free PMC article. Clinical Trial. - Analysis of Body Perception, Preworkout Meal Habits and Bone Resorption in Child Gymnasts.
Amato A, Proia P, Caldara GF, Alongi A, Ferrantelli V, Baldassano S. Amato A, et al. Int J Environ Res Public Health. 2021 Feb 23;18(4):2184. doi: 10.3390/ijerph18042184. Int J Environ Res Public Health. 2021. PMID: 33672264 Free PMC article. - Skeleton and glucose metabolism: a bone-pancreas loop.
Faienza MF, Luce V, Ventura A, Colaianni G, Colucci S, Cavallo L, Grano M, Brunetti G. Faienza MF, et al. Int J Endocrinol. 2015;2015:758148. doi: 10.1155/2015/758148. Epub 2015 Mar 19. Int J Endocrinol. 2015. PMID: 25873957 Free PMC article. Review.